AVDL 외환 뉴스
Avadel Pharma Says FDA Approves Pre-Launch Activities Importation Requests For LUMRYZ
Biopharmaceutical company Avadel Pharmaceuticals plc (AVDL) announced Wednesday that the U.S. Food and Drug Administration has approved its Pre-Launch Activities Importation Requests (PLAIR) for LUMRYZ.
RTTNews
|
709 일 전
